Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria-Reference-Cited by-同舟云学术

Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria

Published:2015-03-17 Issue:3 Volume:10 Page:e0120161
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Avong Yohanna Kamabi,Isaakidis Petros,Hinderaker Sven Gudmund,Van den Bergh Rafael,Ali Engy,Obembe Bolajoko Oladunni,Ekong Ernest,Adebamowo Clement,Ndembi Nicaise,Okuma James,Osakwe Adeline,Oladimeji Olanrewaju,Akang Gabriel,Obasanya Joshua Olusegun,Eltayeb Osman,Agbaje Aderonke Vivian,Abimiku Alash’le,Mensah Charles Olalekan,Dakum Patrick Sunday

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa;JR Andrews;J Infect Dis,2007

2. World Health Organization. Multidrug and extensive drug resistant TB (M/XDR-TB): 2012 global report on surveillance and response. 2012. Available: http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf.

3. Side effects associated with the treatment of multidrug-resistant tuberculosis;T Torun;Int J Tuberc Lung Dis,2005

4. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study;V Leimane;Lancet,2005

5. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies;J Lazarou;JAMA,1998

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase®);Antibiotics;2023-04-25

2. Prevalence and Determinant of Adverse Drug Reactions Among MDR-TB Patients Attending St. Peter’s TB Specialized Hospital, Addis Ababa, Ethiopia;2022-08-03

3. Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study;Frontiers in Pharmacology;2022-06-02

4. Clinical standards for the dosing and management of TB drugs;The International Journal of Tuberculosis and Lung Disease;2022-06-01

5. Frequency and Factors Associated With Adverse Events Among Multi-Drug Resistant Tuberculosis Patients in Pakistan: A Retrospective Study;Frontiers in Medicine;2022-03-01